Replies to post #2232 on BioCurex, Inc.(fka BOCX)

[Headache]

Thanks Bocxman. Now, I understand why persuing certain indications could delay returns for Biocurex, but why would ABT select only a long-term indication? Presumably, they want to make a lot of money as soon as possible. They are a public company after all, and most public companies have their eye on the next quarter or two at the most. They may have their eye on a long-term strategy too, of course, but rarely do companies pass up a chance to make a quick buck.